Correction to: A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD (Nature Medicine, (2024), 30, 2, (382-393), 10.1038/s41591-023-02788-5)

  • Katherine E. Irwin
  • , Pei Jasin
  • , Kerstin E. Braunstein
  • , Irika R. Sinha
  • , Mark A. Garret
  • , Kyra D. Bowden
  • , Koping Chang
  • , Juan C. Troncoso
  • , Abhay Moghekar
  • , Esther S. Oh
  • , Denitza Raitcheva
  • , Dan Bartlett
  • , Timothy Miller
  • , James D. Berry
  • , Bryan J. Traynor
  • , Jonathan P. Ling
  • , Philip C. Wong

Research output: Contribution to journalComment/debate

3 Scopus citations

Abstract

Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-023-02788-5, published online 26 January 2024. In the version of the article initially published, in the “Analysis with reverse transcription PCR” section of the Methods, the HDG F primer originally read 5′-CTCGGAGGCTTCTTCACAGAC-3′ and has now been corrected to 5′-AAGACGCCTGCGCTAAAGAT-3′ in the HTML and PDF versions of the article.

Original languageEnglish
Pages (from-to)1504
Number of pages1
JournalNature medicine
Volume30
Issue number5
DOIs
StatePublished - May 2024

Fingerprint

Dive into the research topics of 'Correction to: A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD (Nature Medicine, (2024), 30, 2, (382-393), 10.1038/s41591-023-02788-5)'. Together they form a unique fingerprint.

Cite this